Psilocybin reduces symptoms of major depression: The Lancet

Published Date: 04 Mar 2023

A new study by Robin von Rotz and his team found that moderate doses of psilocybin for at least two weeks reduced symptoms of depression...

Read Full News

Latest News

Kennedy Broadens Vaccine Advisory Panel's Role to Focus on Risks

U.S. Health Secretary Robert F. Kennedy Jr. on Thursday issued a new charter for a CDC vaccine advisory committee that expands the role of the panel to include a ⁠focus on...

Phage Therapy Gains Momentum in Antibiotic Resistance

Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.

Suspended CDC Lab Testing May Cause Delays, Local Strain

Methods and standards for alternative options may vary.

Patient Nondisclosure May Compromise Diagnosis and Care

Patients often withhold key health information during consultations, which may contribute to delayed diagnosis, unnecessary testing, and suboptimal clinical decisions.

CDC Warns of ‘Rhino Tranq’ in Illicit Drug Supply

The animal sedative has been associated with a severe withdrawal syndrome that does not appear to respond to conventional opioid withdrawal treatment.

Bangladesh Launches Emergency Vaccination Campaign as Measles Outbreak Spreads

Bangladesh on Sunday launched an emergency vaccination campaign targeting more than a million children ⁠as a fast‑spreading measles outbreak sweeps across the...

Todays Updates

Low Income, Education Tied to Depression in Older Adults

Older adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.

Infection Burden High With Myeloma T-Cell Therapies

A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients with advanced non-small cell lung cancer.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Todays Updates

Low Income, Education Tied to Depression in Older Adults

Older adults with chronic disease who have less education, lower income, and no active jobs tend to experience symptoms of depression.

Infection Burden High With Myeloma T-Cell Therapies

A retrospective study suggests a high burden of prolonged, mostly low-grade infections in patients with multiple myeloma who receive T-cell-engaging therapies.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

A national cohort study compares the safety and efficacy of weight-based and fixed-dose pembrolizumab regimens in patients with advanced non-small cell lung cancer.

HER2 ADC Shows Promise in Recurrent Endometrial Cancer

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Latest News

U.S. Health Secretary Robert F. Kennedy Jr. on Thursday issued a new charter for a CDC vaccine advisory committee that expands the role of the panel to include a ⁠focus on...

Growing antimicrobial resistance is prompting renewed interest in phage therapy, with preliminary data indicating improved outcomes when combined with standard antibiotics.

Methods and standards for alternative options may vary.

Patients often withhold key health information during consultations, which may contribute to delayed diagnosis, unnecessary testing, and suboptimal clinical decisions.

The animal sedative has been associated with a severe withdrawal syndrome that does not appear to respond to conventional opioid withdrawal treatment.

Bangladesh on Sunday launched an emergency vaccination campaign targeting more than a million children ⁠as a fast‑spreading measles outbreak sweeps across the...

News All Time

Telemedicine Matches Clinic Visits in IIH Care

Remote consults using optical coherence tomography data show high agreement with traditional clinic evaluations for the management of patients with idiopathic intracranial hypertension.

When Medications May Contribute to Cognitive Decline

Medication-related cognitive impairment is common, mimics neurodegenerative disease, increases with polypharmacy, and may be prevented with regular cognitive assessment monitoring.

Access to Mental Health Support ‘Uneven’ for Young Canadians

The need for mental health support services is high in Canada, especially among youth, but many are unable to access the care they need in a timely manner.

Pope Leo Calls Universal Healthcare a 'Moral Imperative'

Pope Leo has made a plea for countries ⁠to offer their citizens universal healthcare, calling it a "moral imperative" that people have access to ⁠the health services they need.

Will the UK Lose Senior Doctors Earlier Than EU Peers?

Findings from a Medscape survey suggest German and French doctors plan to work longer than their British counterparts — and it’s not just a lifestyle choice.

Human Milk Tied to Fewer Respiratory Admissions in Preemies

Among infants born very preterm, human milk feeding at hospital discharge is associated with fewer respiratory hospital admissions during their first 18 months than exclusive formula feeding.

Depression Predicts Disability Progression in Progressive MS

Depression screening predicts subsequent disability progression in people with primary progressive multiple sclerosis.

World’s Best Hospitals Ranking Puts Mayo Back at No. 1

A new global hospital ranking spanning 32 countries places Mayo Clinic first and highlights strong performances from hospitals in Germany, Switzerland, and Austria.

How Babies Process Pain — and Sugar’s Role in Relieving It

Mounting evidence backs sucrose as an analgesic for newborns — yet their experience of pain remains mysterious.

Environmental Pollution From Pharmaceuticals Raises Concern

Pharmaceutical residues increasingly enter ecosystems across the drug life cycle, prompting calls for coordinated global action grounded in One Health principles.

AAN Issues Guidance on Consumer Wearables in Neurologic Care

New AAN guidance examines how consumer wearable devices can support neurologic care, including epilepsy monitoring and sleep tracking — while cautioning that many of them are insufficiently validated.

Newer Groundwater Linked to Increased PD Risk

Drinking water sourced from newer groundwater or carbonate aquifers is linked to a significantly increased risk for Parkinson’s disease, a new study shows.

When Hearing Fails, Vision Rehab Falls Short

Patients with hearing impairment who receive vision rehabilitation are 42% less likely than those with normal hearing to achieve a meaningful functional improvement, a recent study shows.

AHS Recommends Annual Migraine Screening for Girls and Women

A new recommendation from the American Headache Society calls for annual migraine screening as part of preventive care for girls and women — from adolescence through menopause.

Biologics Don’t Promote Respiratory Infections

Reassuring data support the safety of biologics as an option for asthma care.

Biologics, Phototherapy in Psoriasis: Cost-Benefit Compared

A simulated analysis in psoriasis highlights divergent patient and payer incentives and inconsistent coverage strategies behind barriers to phototherapy uptake.

Recommended News For You

Applications are being accepted for TN Health's post-doctoral fellowship program in gynecologic oncology and minimal access surgery; complete details are available here.

High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

Waiting for a Sharp Increase in Prostate Cancer Cases.

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas

Global inequalities found in cancer research funding

Recommended Articles For You

Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients 

Breaking Down Amyloidosis: Understanding the Disease  

Multi-Omic Rejuvenation of Aged Tissues With Transient Reprogramming and Its Therapeutic Potential 

The Future is Now: Navigating the Precision Revolution in Oncology Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

2.

Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

3.

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

4.

New First-Line Option for Advanced ALK-Positive Lung Cancer

5.

Cardiomyocytes are shielded from chemotherapy damage by mitochondrial proteins.

1.

Unlocking Life Expectancy After Subdural Hematoma: A New Hope

2.

Case Study: The Role of Machine Learning in the Detection of Skin Cancer

3.

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options

4.

The Benefits and Risks of Transurethral Resection of Bladder Tumor 

5.

Optimizing Oncology Practice Revenue: Billing Software, Payer Trends, and Financial Navigation Tools

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

2.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

3.

Navigating the Complexities of Ph Negative ALL - Part V

4.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot